Brief: Diamedica Therapeutics Provides Dm199 Preeclampsia Program Update
18/12/2025 14:12
Dec 18 (Reuters) - DiaMedica Therapeutics Inc DMAC.O: DIAMEDICA THERAPEUTICS PROVIDES DM199 PREECLAMPSIA PROGRAM UPDATE FOLLOWING PRE-IND MEETING WITH FDA DIAMEDICA THERAPEUTICS INC - FDA REQUESTS ADDITIONAL NON-CLINICAL STUDY FOR DM199 DIAMEDICA THERAPEUTICS INC - STUDY RESULTS EXPECTED BY Q2 2026 Source text: ID:nBw3sDzX1a Further company coverage: DMAC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on DiaMedica Therapeutics
See all newsBrief: Diamedica Therapeutics Announces Enrollment Of 200Th Patient In Remedy2 Phase 2/3 Acute Ischemic Stroke Trial
DiaMedica Q2 net loss widen less than expected
DiaMedica Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood
Brief: Diamedica Receives FDA Feedback On Dm199 Preeclampsia Nonclinical Program